Withregard

Regard, formerly known as HealthTensor and operating as Regard Technologies, Inc., develops artificial intelligence software that functions as a diagnostic and documentation co-pilot for physicians. Its algorithms aggregate and analyze the entirety of a patient's electronic health record — including physician notes and lab results — to surface buried but clinically relevant data, recommend diagnoses, and write the resulting diagnoses along with supporting documentation and billing information back into the medical record.

The product is embedded in the clinician's existing workflow rather than a separate application: physicians access it via a link inside the patient record in Epic or Cerner, and can invoke it while drafting a note. The system was initially designed to recognize approximately 50 of the most common medical conditions, and the company has since expanded the platform to additional specialties with the stated goal of covering all admitted patients. Beyond clinical use, Regard positions the output for health systems and revenue cycle teams as a means of improving evidence-based documentation and coding accuracy.

Founding story

Regard was co-founded by Eli Ben-Joseph, who serves as CEO, together with co-founders Nate and Thomas; investors describe the founding team as having backgrounds spanning medicine and data science.

Business model

Regard sells its software to hospitals and health systems, integrating with their existing EMR platforms. Pricing is described as custom and demo-based.

Enterprise software sold to hospitals and health systems; the company positions the product as improving hospital finances through more accurate documentation, coding and billing, alongside physician time savings.

Traction

Since launching in fall 2020, Regard's technology had been used on over 30,000 patients and identified more than 420,000 medical conditions that would otherwise have been missed, and was live in 13 hospitals across seven states as of June 2022. A pilot program found the tool saved physicians 20% of documentation time and improved diagnostic specificity, including a 3.2% increase in specified congestive heart failure.

Latest developments

Following the July 2024 Series B, Regard said it would accelerate development of its core clinical insights platform, invest in fundamental research on large language models, and expand beyond inpatient facilities. The company has since announced an expansion of the platform to new specialties and a partnership with Microsoft Dragon Copilot to be showcased at HIMSS 2026.